**#ClinicalTrials**

Chang Gung Medical Foundation teams up with Gilead Sciences to accelerate early-stage clinical trials, focusing on #oncology. The collaboration aims to advance clinical trials in tumor research, preclinical cooperation, and biomarker/translational studies.

This partnership follows Chang Gung's recent MoU with Boehringer Ingelheim for clinical trial collaboration, demonstrating their commitment to expanding clinical research initiatives.

Dr. Yun-Chang Lin (林永昌), Director of the Clinical Trial Center at Chang Gung Memorial Hospital Linkou branch, emphasizes the significance of local clinical trials in expediting the development and approval of new therapies for the approximately 18% of newly diagnosed cancer cases annually in Taiwan.

Learn more: https://lnkd.in/g8uV_qQb

Follow hashtag#Globalbio for updates!